Investors
Investor & Partnership Opportunities
Canveer Biopharma is currently seeking seed funding to advance AlveoShield™ through
IND-enabling studies and regulatory alignment. We are also interested in strategic
partnerships with Foundations & Organizations committed to advancing neonatal health.
Investment Highlights
Investment Opportunity
Disclaimer: Forward looking statement, all figures and timelines are estimated projections. Actual
results and timelines may differ. Not an offer to sell securities
AlveoShield™ a Differentiated de-risked Opportunity
“While others are exploring, we are validating”
AlveoShield™, The FOUNDATION is BUILT!
“Relevant foundational work is completed before seed fundraising, positions the
AlveoShield™ program ahead of the typical discovery-stage biotech”
Investors Contact
For more information on our pipeline, team, and investment thesis, please contact:
Sherif Louis
CEO
sherif.louis@canveer.com
Forward Looking Statement:
The Investors section contains forward-looking statements, including anticipated development timelines, regulatory
milestones, projected valuations, and potential financing plans. These statements are based on current assumptions and
subject to significant risks and uncertainties. Actual results may differ materially. This content is provided for general
information only and does not constitute an offer to sell or a solicitation to buy any securities of CanVeer Inc. Any
investment opportunity will be offered only in accordance with applicable securities laws and through formal offering
documentation.